Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
6.54
-0.14 (-2.10%)
Nov 20, 2024, 4:00 PM EST - Market closed
Annovis Bio Employees
As of December 31, 2023, Annovis Bio had 16 total employees, including 6 full-time and 10 part-time employees. The number of employees increased by 11 or 220.00% compared to the previous year.
Employees
16
Change (1Y)
11
Growth (1Y)
220.00%
Revenue / Employee
n/a
Profits / Employee
-$2,558,694
Market Cap
85.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| WORK Medical Technology Group LTD | 216 |
| Veru Inc. | 189 |
| Adicet Bio | 143 |
| Allakos | 131 |
| LENSAR | 130 |
| Invivyd | 95 |
| HilleVax | 90 |
| Genelux | 23 |
ANVS News
- 20 days ago - IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio - GlobeNewsWire
- 5 weeks ago - FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs - GlobeNewsWire
- 6 weeks ago - Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases - GlobeNewsWire
- 7 weeks ago - Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations - GlobeNewsWire
- 2 months ago - Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Annovis' Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist - GlobeNewsWire
- 4 months ago - Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap - GlobeNewsWire
- 5 months ago - Annovis stock more than doubled on Tuesday: what happened? - Invezz